On day one, instructor and biotech consultant Kevin Curran, Ph.D., focused on the function of DNA, RNA, proteins, and cell signaling and how each interacts in both healthy and diseased tissue.
Day two built on your newfound molecular biology knowledge, including a more in-depth look at genetic disease and how genetic engineering is used to create personalized medicine options for patients.
The course concluded with a survey of small molecule drugs, biologics, and vaccines and explains how each mitigates disease at the molecular level.
Upon completion of this course, you gained:
AGENDA
Day 1:
8:30-9:00am | Continental Breakfast
9:00-9:15am | Introductions
9:15-10:15am | Industry Overview
10:15-10:30am | Break
10:30-11:30am | Biology: Basis of Biopharma
11:30-12:00pm | DNA: Biopharma’s Blueprint
12:00-12:45pm | Lunch
12:45-1:45pm | DNA: Biopharma’s Blueprint
1:45-2:00pm | Break
2:00-3:15pm | Proteins: Biopharma’s Workhorse
3:15-3:30pm | Wrap-Up
Day 2:
8:30-9:00am | Continental Breakfast
9:00-10:00am | Genetic Engineering
10:00-10:15am | Break
10:15-11:30am | Genetic Basis of Disease
11:30-12:15pm | Genomics: Understanding the Genetic Basis of Disease
12:15-1:00pm | Lunch
1:00-2:15pm | Genomics: Understanding the Genetic Basis of Disease continued
2:15-2:30pm | Break
2:30-3:15pm | Drugs Mitigate Disease: An Overview
3:15-3:30pm | Wrap-Up
For more information please contact:
William Burrows, Director Business Operations
Telephone: 604 669-9909 ext. 101
Email: wburrows@lifesciencesbc.ca
Thank you to our Event Partner:
